Arovella Therapeutics Limited (ASX:ALA)

Australia · Delayed Price · Currency is AUD

0.0890

+0.0040 (4.71%)

Feb 19, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016	Jun '15 Jun 30, 2015	Jun '14 Jun 30, 2014	Jun '13 Jun 30, 2013	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010	Jun '08 Jun 30, 2008	Jun '07 Jun 30, 2007	Jun '06 Jun 30, 2006	Jun '05 Jun 30, 2005
Pharmaceutical Development	17.00K
Pharmaceutical Development Growth	-95.81%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016	Jun '15 Jun 30, 2015	Jun '14 Jun 30, 2014	Jun '13 Jun 30, 2013	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010	Jun '08 Jun 30, 2008	Jun '07 Jun 30, 2007	Jun '06 Jun 30, 2006	Jun '05 Jun 30, 2005
Australia	17.00K
Australia Growth	-95.81%